ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jan 23, 2017
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-19+105,000→ 105,000 totalExercise: $4.85Exp: 2027-01-18→ Common Stock (105,000 underlying) - Award
Common Stock
2017-01-19+3,958→ 3,958 total
Footnotes (1)
- [F1]This option was granted on January 19, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.